To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regime…

Rhegmatogenous Retinal Detachment

~Estimated

~$10 – $7,500

Massachusetts Eye and Ear InfirmaryNCT05331664

Phase 2

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

I. Title Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial * Today's Date: Septe…

Proliferative VitreoretinopathyRhegmatogenous Retinal Detachment

~Estimated

~$10 – $5,625

Cincinnati Eye Institute, Southwest OhioNCT06541574

Phase 1

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Primary Rhegmatogenous Detachments and Retinal Detachment Due to Proliferative Vitreoretinopathy or Open-Globe Injury: A Phase I/II Clinical Trial

This study has two main objectives. The first objective is to study the pharmacokinetics of topical netarsudil administration in the posterior segment of the e…

Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy

~Estimated

~$10 – $7,500

Massachusetts Eye and Ear InfirmaryNCT06033703